Glenmark in talks to sell up to 30% in API biz to PremjiInvest

The pharma group plans to sell minority stake for $150m in their new subsidiary of active pharmaceutical ingredient products. Discussions are ongoing with True North

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2ZpSkxM
via Latest News of India